Fact CheckerSign in

NCT06514924Completed

Secular Change of Height in Turkish Young Adults

Young Turkish Adults Show a Continuing Positive Secular Change of Height But a Worrying Increase of Overweight in Males

Source: ClinicalTrials.gov · Last updated 23 Jul 2024

Brief summary (registry, in English)

Current Turkish growth reference charts based on anthropometric measurements of individuals with high socioeconomic status in Istanbul in 1989-2002 (TK2002) had shown an increase of mean adult height (1.4 and 2.7 cm in males and females) compared with 1978. Given recent improvements in nutrition, hygiene and access to preventive health services, it is hypothesized that this positive secular trend may continue. A prior power analysis (95% power) showed that at least 122 subjects of each sex were needed to detect a 1.8 cm height increase (p=0.05) vs TK2002. In 2023-2024 a sample of Turkish young adults (18-26 years) was randomly selected from 65,000 students at Istanbul University, originating from every region of Turkey (TK2024). Height, weight, and socioeconomic status (SES, categorized into four groups) were recorded and body mass index (BMI) was calculated. Adult height and BMI were compared with TK2002 and with young adults of Turkish origin living in the Netherlands measured in 2009 (NL2009).

Status (registry)
Completed
Study type
Observational
Enrollment
465 (actual)
First submitted
9 Jul 2024
Start date
1 Sept 2023
Primary completion date
1 Jun 2024
Lead sponsor
Istanbul University
Diseases
Obesity
NCT number
NCT06514924

What you commit to

  • Study type: Observational
  • Participants enrolled: 465
  • From 1 Sept 2023 to the primary completion date, 1 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participants who have received growth hormone treatment are excluded.

Other illness

  • Chronic Disease:
  • Participants with a diagnosis of any chronic disease are excluded.
  • History of Surgery Affecting Growth:
  • Participants with a history of any surgery that could affect linear growth are excluded.

Other

  • Growth Retardation:
  • Participants with a diagnosis of growth retardation are excluded.
  • Growth Hormone Administration:
  • Parental Origin:
  • Participants with a parent born outside of Turkey are excluded.
  • Birth Height or Weight:
  • Participants with a birth height or weight less than -2 standard deviations (SDS) are excluded.
  • Current Height or BMI:
  • Participants with a current height or BMI less than -3 SDS or greater than +3 SDS are excluded.

Who the study is looking for

  • Age:
  • Participants must be between 18 and 26 years old.
  • Student Status:
  • Participants must be current students at Istanbul University.
  • Voluntary Participation:
  • Participants must voluntarily agree to participate in the study and provide informed, written consent.

Age in the registry: 18 years to 26 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Istanbul University
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.